RxDoctor Payments Data

Aaron Haire, DPM

Foot & Ankle Surgery · West Columbia, SCNPI 1144668419

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (31.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Celularity Inc. at 29.3% of the total. Reporting peaked in 2019 at $20,437 and has fallen 85.9% since, to $2,885 in 2024.

$30,060in general payments, 2019–2025

Across 168 payments — averaging $178.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Celularity Inc.$9K
  • Arthrex$8K
  • Peerless Surgical Inc.$8K
  • Medical Device Business Services, Inc.$2K
  • Medartis Inc.$585
  • Medline Industries LP$543
  • plus $2K from 27 others

What the payments were for

  • Consulting fees$8,25127%
  • Travel & lodging$8,19127%
  • Food & beverage$4,22214%
  • Education$9,38531%
  • Gifts$110%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$30,060 in reported general payments places this provider in the 80th percentile of 87 foot & ankle surgery providers in South Carolina.

See all foot & ankle surgery providers in South Carolina

Medicare billing

Part B allowed, 2024
$143,779
Medicare patients
333
Services billed
1,852

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JubliaEfinaconazole36$38,920
Ciclopirox365$10,115
Ketoconazole167$4,097
Terbinafine Hcl69$1,320
Celecoxib21$575
Ammonium Lactate24$554
Pregabalin25$420
Allopurinol15$332
Naproxen28$252
Gabapentin15$231
Ibuprofen18$104
Amoxicillin36$90
Methylprednisolone15$86

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in West Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →